Linagliptin Methyldimer

CAS : 1418133-47-7

Ref. TR-L465910

Informations sur le produit

• Nom: Linagliptin Methyldimer
• Synonymes: 8-[(3R)-3-Amino-1-piperidinyl]-1-[[4-[[2-[[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]methyl]-1,4-dihydro-4-methyl-4-quinazolinyl]methyl]-2-quinazolinyl]methyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1H-purine-2,6-dione, 8-((R)-3-Aminopiperidin-1-yl)-1-((4-((2-((8-((R)-3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)-4-methyl-1,4-dihydroquinazolin-4-yl)methyl)quinazolin-2-yl)methyl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione, Linagliptin Dimer Impurity

Description

Impurity Linagliptin Dimer Impurity
Stability Light Sensitive
Applications Linagliptin Methyldimer inhibits dipeptidylpeptidase-IV (DPP-IV) and may be used in the treatment of type 2 diabetes.
References Prabavathy, N. et al.: Int. J. Pharm. Bio. Sci., 2, 438 (2011); Deacon, C.F.: Diab. Obes. Metab., 13, 7 (2011);

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 945.08
• Formule: C₅₀H₅₆N₁₆O₄
• Degré de pureté: ~90%
• Couleur/Forme: Neat
• InChI: InChI=1S/C16H11N3O4S/c20-14-9-5-1-2-6-10(9)18-16(21)13(14)15-17-11-7-3-4-8-12(11)24(22,23)19-15/h1-8H,(H,17,19)(H2,18,20,21)
• Code InChI: InChIKey=ZHQPRBRAQYOKMI-UHFFFAOYSA-N
• SMILES: O=c1[nH]c2ccccc2c(O)c1C1=NS(=O)(=O)c2ccccc2N1